
You can purchase shares of Adarx Pharmaceuticals (NASDAQ:ADRX) through any online brokerage.
Other companies in Adarx Pharmaceuticals’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).
Adarx Pharmaceuticals has a consensus price target of $34.33.
The stock price for Adarx Pharmaceuticals (NASDAQ: ADRX) is $12.79 last updated November 20, 2026 at 4:00 PM EST.
There are no upcoming dividends for Adarx Pharmaceuticals.
Adarx Pharmaceuticals does not have any upcoming earnings scheduled.
There is no upcoming split for Adarx Pharmaceuticals.
Adarx Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Adarx Pharmaceuticals Inc is a late-clinical stage biotechnology company focused on developing next-generation siRNA therapeutics designed to treat a broad spectrum of diseases. Its pipeline includes three clinical-stage programs and two advanced...